Global Blood Products Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Blood Products market size will reach 41,602 Million USD in 2025 and is projected to reach 68,304 Million USD by 2032, with a CAGR of 7.34% (2025-2032). Notably, the China Blood Products market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Blood products are therapeutic substances derived from blood and used in the treatment of various medical conditions or to replace lost blood components. Common blood products include plasma, platelets, and red blood cells, which are collected from blood donors and processed for use in transfusions. These products are essential for treating a range of conditions such as anemia, bleeding disorders, and certain types of cancer. They must be handled with care to ensure that they are safe for use and free from infectious agents.
The major global suppliers of Blood Products include CSL, Creat Group Corporation, Grifols, Takeda, Octapharma, Kedrion, Biotest, China Biologic Products, Sanquin, LFB, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Blood Products. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Blood Products market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Blood Products market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Blood Products industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Blood Products Include:
CSL
Creat Group Corporation
Grifols
Takeda
Octapharma
Kedrion
Biotest
China Biologic Products
Sanquin
LFB
Blood Products Product Segment Include:
Albumin
Immunoglobulin
Clotting Factor
Others
Blood Products Product Application Include:
Bleeding Wound
Immunodeficiency
HBV
Tetanus
Rabies
Hemophilia
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Blood Products Industry PESTEL Analysis
Chapter 3: Global Blood Products Industry Porter's Five Forces Analysis
Chapter 4: Global Blood Products Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Blood Products Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Blood Products Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Blood Products Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Blood Products market size will reach 41,602 Million USD in 2025 and is projected to reach 68,304 Million USD by 2032, with a CAGR of 7.34% (2025-2032). Notably, the China Blood Products market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Blood products are therapeutic substances derived from blood and used in the treatment of various medical conditions or to replace lost blood components. Common blood products include plasma, platelets, and red blood cells, which are collected from blood donors and processed for use in transfusions. These products are essential for treating a range of conditions such as anemia, bleeding disorders, and certain types of cancer. They must be handled with care to ensure that they are safe for use and free from infectious agents.
The major global suppliers of Blood Products include CSL, Creat Group Corporation, Grifols, Takeda, Octapharma, Kedrion, Biotest, China Biologic Products, Sanquin, LFB, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Blood Products. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Blood Products market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Blood Products market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Blood Products industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Blood Products Include:
CSL
Creat Group Corporation
Grifols
Takeda
Octapharma
Kedrion
Biotest
China Biologic Products
Sanquin
LFB
Blood Products Product Segment Include:
Albumin
Immunoglobulin
Clotting Factor
Others
Blood Products Product Application Include:
Bleeding Wound
Immunodeficiency
HBV
Tetanus
Rabies
Hemophilia
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Blood Products Industry PESTEL Analysis
Chapter 3: Global Blood Products Industry Porter's Five Forces Analysis
Chapter 4: Global Blood Products Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Blood Products Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Blood Products Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Blood Products Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Blood Products Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Blood Products Product by Type
- 1.2.1 Albumin
- 1.2.2 Immunoglobulin
- 1.2.3 Clotting Factor
- 1.2.4 Others
- 1.3 Blood Products Product by Application
- 1.3.1 Bleeding Wound
- 1.3.2 Immunodeficiency
- 1.3.3 HBV
- 1.3.4 Tetanus
- 1.3.5 Rabies
- 1.3.6 Hemophilia
- 1.3.7 Others
- 1.4 Global Blood Products Market Size Analysis (2020-2032)
- 1.5 Blood Products Market Development Status and Trends
- 1.5.1 Blood Products Industry Development Status Analysis
- 1.5.2 Blood Products Industry Development Trends Analysis
- 2 Blood Products Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Blood Products Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Blood Products Market Analysis by Country
- 4.1 Global Blood Products Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Blood Products Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Blood Products Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Blood Products Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Blood Products Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Blood Products Market Revenue and Growth Rate (2020-2032)
- 4.5 China Blood Products Market Revenue and Growth Rate (2020-2032)
- 4.6 France Blood Products Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Blood Products Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Blood Products Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Blood Products Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Blood Products Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Blood Products Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Blood Products Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Blood Products Market Revenue and Growth Rate (2020-2032)
- 4.14 India Blood Products Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Blood Products Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Blood Products Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Blood Products Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Blood Products Market Revenue by Key Suppliers (2021-2025)
- 5.2 Blood Products Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Blood Products Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Blood Products Market Analysis by Type
- 6.1 Global Blood Products Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Blood Products Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 CSL
- 7.1.1 CSL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 CSL Blood Products Product Portfolio
- 7.1.3 CSL Blood Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Creat Group Corporation
- 7.2.1 Creat Group Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Creat Group Corporation Blood Products Product Portfolio
- 7.2.3 Creat Group Corporation Blood Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Grifols
- 7.3.1 Grifols Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Grifols Blood Products Product Portfolio
- 7.3.3 Grifols Blood Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Takeda
- 7.4.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Takeda Blood Products Product Portfolio
- 7.4.3 Takeda Blood Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Octapharma
- 7.5.1 Octapharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Octapharma Blood Products Product Portfolio
- 7.5.3 Octapharma Blood Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Kedrion
- 7.6.1 Kedrion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Kedrion Blood Products Product Portfolio
- 7.6.3 Kedrion Blood Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Biotest
- 7.7.1 Biotest Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Biotest Blood Products Product Portfolio
- 7.7.3 Biotest Blood Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 China Biologic Products
- 7.8.1 China Biologic Products Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 China Biologic Products Blood Products Product Portfolio
- 7.8.3 China Biologic Products Blood Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Sanquin
- 7.9.1 Sanquin Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Sanquin Blood Products Product Portfolio
- 7.9.3 Sanquin Blood Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 LFB
- 7.10.1 LFB Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 LFB Blood Products Product Portfolio
- 7.10.3 LFB Blood Products Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Blood Products Industry Chain Analysis
- 8.2 Blood Products Product Downstream Application Analysis
- 8.2.1 Global Blood Products Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Blood Products Revenue and Forecast by Application (2020-2032)
- 8.3 Blood Products Typical Downstream Customers
- 8.4 Blood Products Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
